Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
300 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 298 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
362 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2021-02-25 | 2021-09-16 | 134743 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139297 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-08 | 2023-07-28 | 194113 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195475 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2024-11-08 | 2025-02-20 | 242355 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97602 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2021-03-25 | 2021-09-16 | 136283 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195469 |
ACT ENALAPRIL | 8MG | TABLET | Resolved | 2018-09-12 | 2019-03-12 | 61343 |
ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2020-07-16 | 2020-07-30 | 120482 |
ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-04-27 | 2023-07-14 | 190776 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2017-08-24 | 2017-10-10 | 20326 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195646 |
ACT ENALAPRIL | 4MG | TABLET | Resolved | 2021-04-08 | 2021-09-09 | 137203 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231583 |
TEVA-ACYCLOVIR | 800MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256128 |
TEVA-ACYCLOVIR | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256122 |
TEVA-ACYCLOVIR | 400MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256125 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |